Cascade Prodrug Inc
We have a lead compound in preclinical trials which in tumor models shows significant improvement in safety and efficacy using the tumors own microenvironment
- Stage Product In Development
- Industry Biotechnology
- Location Eugene, OR, USA
- Currency USD
- Founded September 2009
- Employees 4
- Incorporation Type C-corp
- Website cascadeprodrug.com
Company Summary
Cascade Prodrug Inc is in preclinical development of a novel drug utilizing it's proprietary technology platform. This compound is a prodrug derivative of blockbuster FDA approved agent to treat cancer. Data suggests this new form has the potential for significant improvement to the theraputic index of the parent. Our commercial strategy is to modify these parent drugs, create new prodrugs, then license/exit with a major pharmaceutical company.
Team
-
Augie SickCofounder
-
CoFounder
Advisors
-
Ernie Bootsma, Ater WynneLawyerUnconfirmedPeter Buss KS&CoAccountantUnconfirmed
Previous Investors
-
Oregon Angel FundUnconfirmedWillamette Angel FundUnconfirmedPrivate Side InvestorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.